Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by pmartino
Group name EquipePM
Item Type Journal Article
Title Oncovascular compartmental resection for retroperitoneal soft tissue sarcoma with vascular involvement
Creator Bertrand et al.
Author M. M. Bertrand
Author S. Carrere
Author L. Delmond
Author S. Mehta
Author P. Rouanet
Author L. Canaud
Author P. Alric
Author F. Quenet
Abstract OBJECTIVE: This study analyzed the outcomes of a series of consecutive patients diagnosed with a retroperitoneal soft tissue sarcoma (RSTS) with vascular involvement and who underwent a multidisciplinary operation. METHODS: Between 2000 and 2013, 126 patients were referred for oncovascular surgery in our institution. Among these, 31 consecutive patients underwent operations for RSTS with vascular involvement. A vascular/oncologic team determined the surgical strategy preoperatively. RESULTS: Median follow-up was 34.4 months (interquartile range, 48.1 months). Twenty patients (65%) were referred for primary RSTS and 11 (35%) for local recurrence. The most common histologic diagnosis was liposarcoma (54.8%), mainly high-grade and intermediate-grade RSTS. Prosthetic grafts were usually used for vascular reconstruction. Median hospital stay was 17 days (interquartile range, 14.5; range, 7-190 days). The grade 3 and 4 morbidity rate was 19.3%. Each resection was macroscopically complete (R0-R1). Median progression-free survival was 10 months, and median overall survival was not reached. Overall survival rates were 77.4% at 1 year and 61.3% at 3 years. CONCLUSIONS: Vascular resection and reconstruction are safe and feasible in case of RSTS. The morbidity rate was acceptable, and there were no perioperative deaths. Despite recurrence rates that remain high, oncovascular resection enhances resection margins and allows encouraging survival results for patients often considered as nonresectable.
Publication J Vasc Surg
Date Jun 30 2016
Journal Abbr Journal of vascular surgery
DOI 10.1016/j.jvs.2016.04.006
ISSN 1097-6809 (Electronic) 0741-5214 (Linking)
Call Number IMPACT: 3.294
Extra IMPACT: 3.294
Tags clinic
Date Added 2018/07/20 - 09:15:34
Date Modified 2019/06/11 - 10:07:41
Notes and Attachments (Note)
(Note)
27374069 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés